Understanding Lactobacillus helveticus Role in Canine Health
How this heat-inactivated postbiotic strengthens the gut barrier, restores microbial balance, and supports whole-body health from the inside out
Summary
At the heart of Bonza’s One Gut. Whole Dog. philosophy sits a simple but powerful idea: when the gut thrives, the whole dog benefits. Every organ system — from the immune network to the skin, joints, brain, and heart — depends on signals that originate in the gastrointestinal tract. That’s why selecting the right microbial support isn’t just about digestion; it’s about building a foundation for lifelong health.
Lactobacillus helveticus HA-122 is one of the most thoroughly researched lactic acid bacteria in Bonza’s formulations. Originally classified as Lactobacillus acidophilus HA-122, this strain was reclassified following advances in genomic taxonomy that revealed it belongs to the distinct L. helveticus species (1). The reclassification reflects more precise genetic identification rather than any change to the organism itself — the strain’s beneficial properties remain exactly as documented across more than a decade of research.
Bonza uses HA-122 in its heat-inactivated (tyndallised) postbiotic form. Unlike live probiotics that must survive stomach acid and colonise the gut to exert their effects, postbiotics deliver their benefits through the bioactive compounds embedded in the bacterial cell wall and released during inactivation — including surface-layer proteins, peptidoglycan fragments, and metabolic by-products (2). This makes them inherently more stable during manufacture, storage, and transit through the canine digestive system, while retaining the ability to interact with the host’s immune receptors and epithelial cells.
What Makes HA-122 Different from Generic Probiotics?
Probiotic efficacy is strain-specific. Two bacteria from the same species can produce entirely different health outcomes depending on their genetic makeup, surface structures, and metabolic capabilities. HA-122 is a proprietary strain produced by Lallemand Health Solutions, and the research supporting it cannot be generalised from studies on other L. helveticus strains such as R0052, LAFTI L10, or NBIMCC 8269.
What distinguishes HA-122 in the scientific literature is the growing body of evidence demonstrating that it retains significant biological activity even after heat inactivation. In a zebrafish feeding trial, both live and heat-inactivated forms of HA-122 strengthened gut barrier function — but through different mechanisms. The live form increased intestinal villi length, while the heat-inactivated form reduced lamina propria width, suggesting a dampening of baseline mucosal inflammation. Both forms upregulated the tight junction scaffolding protein zo-2a and increased goblet cell populations and intraepithelial lymphocyte counts (3). These findings confirm that the postbiotic form of HA-122 is not a “degraded” version of the live organism but an active biological preparation with its own distinct mechanistic profile.
This matters for practical formulation. A postbiotic can be incorporated into dry food, baked treats, and supplements without the cold-chain requirements or viability concerns that constrain live probiotics — while still delivering measurable physiological effects at the gut epithelial interface.
Strengthening the Gut Barrier
The intestinal epithelium is your dog’s largest interface with the outside world. A single layer of cells, connected by tight junction proteins such as zonula occludens (ZO), claudins, and occludin, must simultaneously absorb nutrients and exclude pathogens, toxins, and undigested macromolecules. When this barrier is compromised — a condition often described as “leaky gut” — the consequences extend far beyond the digestive tract, triggering systemic inflammation that can manifest as skin conditions, joint stiffness, behavioural changes, and immune dysregulation.
HA-122 supports barrier integrity through multiple complementary pathways. The Rawling et al. (2023) zebrafish study demonstrated that dietary administration of HA-122 at 6 × 10⁶ cells per gram of feed significantly upregulated gene expression of zo-2a, a critical intracellular scaffold protein that anchors tight junctions to the actin cytoskeleton (3). This wasn’t a marginal effect — it occurred alongside measurable increases in villi length (indicating greater absorptive surface area), expanded goblet cell populations (which produce the protective mucus layer), and elevated intraepithelial lymphocyte counts (the gut’s first-responder immune cells).
The species-level evidence reinforces these findings. The surface-layer protein (SlpA) that characterises L. helveticus — constituting approximately 45% of the cell wall dry weight — has been shown to reduce NF-κB activation in intestinal epithelial Caco-2 cells, both at baseline and under inflammatory stimulation with IL-1β (2). This dual capacity to reinforce the physical barrier while simultaneously calming inflammatory signalling at the epithelial surface is what makes L. helveticus postbiotics particularly valuable in the context of canine gut health, where subclinical barrier dysfunction is increasingly recognised as an underlying driver of chronic conditions.
Restoring and Maintaining Microbial Balance
A is characterised by diversity, resilience, and a favourable balance between beneficial and potentially harmful bacterial populations. HA-122 has been tested in two sophisticated canine in vitro gut models that replicate the conditions of the large intestine, providing direct evidence of its effects on the .
Enriching Beneficial Populations
In the Simulator of the Canine Intestinal Microbial Ecosystem (SCIME), a validated model that uses faecal inocula from dogs with soft stools, a blend containing heat-killed HA-122 alongside prebiotics (baobab, acacia gum, and yeast fractions) produced significant shifts in microbial composition. Bifidobacterium populations were enriched to biologically relevant levels, Prevotella abundance increased, and butyrate-producing Fusobacterium and Ruminococcaceae expanded — while the potentially pathogenic Proteobacteria family Sutterellaceae declined (1). These shifts mirror exactly the kind of microbial rebalancing that veterinary gastroenterologists aim to achieve in dogs with dysbiosis.
Boosting Short-Chain Fatty Acid Production
Short-chain fatty acids (SCFAs) — particularly acetate, propionate, and butyrate — are the primary metabolic currency of a healthy gut. Butyrate fuels colonocytes (the cells lining the colon), strengthens tight junctions, and exerts anti-inflammatory effects through histone deacetylase inhibition. Propionate supports hepatic gluconeogenesis and lipid metabolism. Acetate influences appetite regulation and systemic energy balance.
The SCIME model demonstrated that the HA-122-containing blend increased acetate production, with donor-dependent increases in propionate and butyrate (1). In the CANIM-ARCOL canine gut model, HA-122 helped preserve total SCFA concentrations above 100 mM during antibiotic treatment, compared to approximately 80 mM in untreated controls (4). This preservation of SCFA output during microbial disruption is particularly significant — it suggests that HA-122 postbiotics help maintain the metabolic productivity of the gut ecosystem even when live bacterial populations are under assault.
Supporting Gut Recovery After Antibiotics
Antibiotic treatment, while sometimes necessary, is one of the most significant disruptions a dog’s microbiome can experience. Broad-spectrum antibiotics like metronidazole and enrofloxacin — commonly prescribed in veterinary practice — don’t distinguish between harmful and beneficial bacteria, often triggering an overgrowth of opportunistic pathogens (particularly Enterobacteriaceae) and a prolonged loss of microbial diversity.
Deschamps et al. (2025) specifically tested heat-inactivated HA-122 in the CANIM-ARCOL model during and after simulated antibiotic treatment with metronidazole and enrofloxacin. The results were striking: HA-122 mitigated the Enterobacteriaceae bloom by up to 75% in relative abundance (P<0.05), accelerated bacterial load recovery by approximately 1.5 log₁₀ copies per millilitre, and restored microbial diversity (measured by Shannon index) to baseline levels by day 14, compared to day 16 in controls (4). The postbiotic also upregulated norspermidine biosynthesis pathways, polyamines that play a role in mucosal healing and cell proliferation.
For dog owners whose pets require antibiotic courses, this evidence suggests that concurrent or follow-up postbiotic support with HA-122 may help the gut microbiome recover faster and more completely — reducing the risk of antibiotic-associated diarrhoea and the secondary health consequences of prolonged dysbiosis.
Immune Modulation: Balancing Defence and Tolerance
Approximately 70–80% of your dog’s immune system resides in the gut-associated lymphoid tissue (GALT). The immune cells embedded in the intestinal wall must constantly distinguish between harmless food antigens and genuine threats — a balancing act that requires precise calibration. When this system tips toward overactivation, the result can be allergies, inflammatory bowel conditions, and autoimmune-like responses. When it underperforms, the dog becomes vulnerable to infections.
L. helveticus postbiotics interact with the immune system through Toll-like receptor 2 (TLR-2), a pattern recognition receptor on the surface of macrophages and dendritic cells. Upon recognition, the bacterial surface-layer protein triggers a carefully balanced cytokine response: it induces tumour necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2) in macrophages, priming innate defence, while simultaneously maintaining interleukin-10 (IL-10) production at levels sufficient to prevent excessive inflammation (2, 5). This is not an either/or response — it’s the hallmark of immune regulation rather than simple stimulation.
At the epithelial level, the SlpA protein reduces NF-κB activation, the master transcription factor driving inflammatory gene expression. Studies using the intestinal Caco-2 cell model demonstrated that L. helveticus MIMLh5 was significantly more effective at suppressing NF-κB than the well-established commercial probiotic L. acidophilus NCFM (2). While these studies used different strains of L. helveticus, they establish a species-level mechanism that is consistent with the surface-layer protein architecture shared across L. helveticus strains, including HA-122.
The immunomodulatory properties of lactobacilli-derived postbiotics have been further validated in zebrafish models, which share fundamental innate immune pathways with mammals. Nikapitiya et al. (2026) confirmed that postbiotic preparations from lactobacilli species activate immunomodulatory responses in vivo, reinforcing the mechanistic basis for using heat-inactivated preparations in companion animal nutrition (6).
Beyond the Gut: How HA-122 Supports Whole-Body Health
Bonza’s One Gut. Whole Dog. framework recognises that the gut doesn’t operate in isolation. Through a network of signalling pathways known as the gut-organ axes, microbial metabolites, immune signals, and neural messengers produced in the gut influence the function of every major organ system. HA-122’s ability to modulate the microbiome, produce SCFAs, strengthen the gut barrier, and calibrate immune responses positions it as a contributor across multiple axes of health.
Gut-Immune Axis
By balancing pro- and anti-inflammatory cytokine production and reducing NF-κB-driven inflammation at the epithelial barrier, HA-122 postbiotics support appropriate immune vigilance without chronic overactivation — relevant for dogs prone to allergies, recurring skin conditions, or environmental sensitivities.
Gut-Skin Axis
Skin health is intimately connected to gut barrier integrity. When intestinal permeability increases, circulating endotoxins and inflammatory mediators can trigger or exacerbate dermatological conditions. By reinforcing tight junctions and expanding the protective mucus layer, HA-122 helps maintain the upstream barrier that protects skin health from the inside.
Gut-Brain Axis
L. helveticus is one of the most studied species in gut-brain axis research, with documented capacity for gamma-aminobutyric acid (GABA) production through glutamate decarboxylase activity. GABA is the primary inhibitory neurotransmitter in the mammalian central nervous system, and its production by gut microbiota has been linked to reduced anxiety-like behaviour and improved stress resilience in animal models. While HA-122-specific gut-brain studies in dogs are not yet available, the species-level evidence provides a strong mechanistic rationale (2).
Gut-Metabolic Axis
The SCFAs produced through HA-122-mediated microbiome modulation influence metabolic health through multiple pathways. Propionate modulates hepatic lipid metabolism and gluconeogenesis, butyrate improves insulin sensitivity through G-protein coupled receptor signalling, and acetate participates in appetite regulation. For dogs maintaining a healthy weight or managing metabolic conditions, these metabolic contributions from a well-functioning microbiome are meaningful (1, 4).
Digestive Comfort: Evidence from Clinical Use
While canine-specific clinical trials on HA-122 alone are still emerging, the strain has been tested in a notable human clinical trial that directly validates its tyndallised (heat-killed) form. Martinelli et al. (2017) conducted a multicentre randomised controlled trial in 176 infants with colic, comparing tyndallised L. acidophilus HA-122 (at 2 × 10⁹ CFU equivalent) in combination with chamomile and melissa extracts against L. reuteri DSM 17938 and simethicone. The HA-122 combination achieved a 95% responder rate with a mean daily crying time reduction of 44 minutes (P<0.001 vs simethicone), performing comparably to the gold-standard probiotic L. reuteri (7).
This study is significant for several reasons. It uses the exact strain and the exact postbiotic form that Bonza incorporates. It demonstrates clinical efficacy on digestive comfort — a primary concern for dog owners dealing with sensitive stomachs, intermittent loose stools, or food transitions. And it provides regulatory-grade evidence (registered at ClinicalTrials.gov: NCT02708238) that tyndallised HA-122 is both safe and effective in a vulnerable population.
Working Together: HA-122 in Bonza’s Gut Health System
No single ingredient works in isolation. HA-122 achieves its greatest impact when paired with Bonza’s complete nutritional ecosystem — the Superfoods & Ancient Grains plant-based food providing the prebiotic and microbial foundation, and the Bioactive Bites supplement range delivering concentrated postbiotic and botanical support. Together, this food-plus-supplement approach creates complementary mechanisms that amplify each other’s effects.
Chicory root inulin acts as the prebiotic fuel that feeds the beneficial bacteria HA-122 helps to establish. While HA-122 shifts the microbiome toward a more favourable composition, inulin provides the fermentable substrate that sustains those populations and drives ongoing SCFA production. This prebiotic-postbiotic partnership is a direct expression of the synbiotic principle (1).
Calsporin® (Bacillus velezensis DSM 15544) complements HA-122 through a different mechanism entirely. As a spore-forming probiotic, Calsporin survives the acidic stomach environment with near-complete viability, germinating in the intestine where it produces antimicrobial compounds and competes with pathogenic bacteria for adhesion sites. While HA-122 postbiotics modulate the immune response and strengthen the epithelial barrier from the luminal surface, Calsporin provides active, living microbial competition within the gut ecosystem. Together, they address gut health through both passive barrier support and active microbial management.
Yeast cell wall fractions (MOS and beta-glucans) work alongside HA-122 to support immune function. Beta-glucans activate innate immune cells through dectin-1 receptor signalling, while mannan-oligosaccharides (MOS) bind pathogenic bacteria and prevent their adhesion to the gut wall. This multi-layered defence strategy — postbiotic immune calibration, prebiotic nourishment, live probiotic competition, and yeast-derived pathogen binding — reflects Bonza’s formulation philosophy of addressing gut health through complementary, evidence-based mechanisms.
How to Support Your Dog’s Gut Health with Postbiotic L. helveticus HA-122
Incorporating postbiotic support into your dog’s routine doesn’t require complicated protocols. These evidence-based steps will help you maximise the benefits of HA-122 alongside a balanced diet.
- Start with a complete, microbiome-supportive diet.
Postbiotics work best within a nutritional framework that also provides prebiotic fibre, antioxidants, and balanced macronutrients. Bonza’s Superfoods & Ancient Grains complete food delivers chicory root inulin, Calsporin probiotic, TruPet postbiotic and yeast cell wall fractions — creating the ideal gut environment for postbiotic supplementation to build on.
- Add targeted postbiotic support through Bonza’s Bioactive Bites.
Bonza’s Bioactive Bites supplement range — including Belly (digestion), Biotics (gut health), and Boost (vitality) — delivers HA-122 alongside condition-targeted botanical and nutraceutical ingredients. Pairing these supplements with a complete, prebiotic-rich diet creates a layered approach to gut health: the food establishes the microbial foundation, while the postbiotic amplifies the benefits.
- Maintain daily consistency.
The microbial and immune-modulatory benefits of postbiotics are cumulative and depend on regular exposure. Unlike pharmaceutical interventions that produce immediate effects, postbiotic-driven improvements in gut barrier function, SCFA production, and microbial diversity build over days to weeks of consistent feeding.
- Provide extra support during and after antibiotic treatment.
If your dog requires antibiotics, continuing or introducing postbiotic supplementation during the course can help mitigate the disruption to the microbiome. Research shows HA-122 reduces pathogenic overgrowth during antibiotic exposure and accelerates microbial recovery afterward (4). Discuss supplementation timing with your veterinarian.
- Transition foods gradually.
When changing your dog’s diet, a gradual transition over 7–10 days allows the gut microbiome to adapt to new substrates. During this period, the barrier-strengthening and microbiome-stabilising effects of HA-122 postbiotics can help reduce the digestive upset that often accompanies abrupt dietary changes.
- Monitor stool quality as a gut health indicator.
Firm, well-formed stools with minimal odour are a practical indicator of a healthy, well-functioning microbiome. If your dog’s stools are consistently soft, mucous-coated, or highly variable, this may signal dysbiosis or barrier compromise — exactly the conditions that HA-122 postbiotics are designed to address.
Frequently Asked Questions
Yes. L. helveticus has a long history of safe use in both human and animal nutrition. The species holds Qualified Presumption of Safety (QPS) status with EFSA, and L. helveticus NBIMCC 8269 is specifically authorised as a feed additive for dogs and cats in the European Union (EFSA Journal 2022;20(9):7423). HA-122 is produced by Lallemand Health Solutions, a GMP-certified manufacturer with extensive safety documentation. The tyndallised form used in Bonza products carries an additional safety margin, as heat inactivation eliminates any theoretical risk of live bacterial translocation in immunocompromised animals (3, 7).
A probiotic is a live microorganism that, when administered in adequate amounts, confers a health benefit on the host. A postbiotic is a preparation of inanimate (non-living) microorganisms and/or their components that confers a health benefit. Postbiotics include heat-killed bacterial cells, cell wall fragments, surface-layer proteins, and metabolic by-products. HA-122 in Bonza products is a postbiotic — heat-inactivated to ensure stability while retaining its biological activity at the gut epithelial surface (2, 3).
Postbiotics are generally well-tolerated alongside veterinary medications. In fact, the evidence from Deschamps et al. (2025) specifically demonstrates that HA-122 supports gut microbiome recovery during and after antibiotic treatment (4). However, if your dog is on immunosuppressive medication or has a complex medical condition, it’s always advisable to consult your veterinarian before introducing any new supplement.
Most dog owners report noticeable improvements in stool quality within 2–4 weeks of consistent feeding. Immune-modulatory and barrier-strengthening effects are cumulative and may take 4–8 weeks to fully manifest. For dogs with chronic digestive sensitivities, long-term daily supplementation provides the most consistent benefits.
Heat inactivation offers several practical and scientific advantages. It ensures complete stability during manufacture, shipping, and storage without requiring refrigeration or cold-chain logistics. It eliminates viability concerns in dry food formats. And crucially, the research demonstrates that heat-inactivated HA-122 retains significant biological activity — including gut barrier reinforcement, immune modulation, and SCFA preservation — through its surface-layer proteins and cell wall components (3, 4). Bonza’s formulation pairs this postbiotic with a live spore-forming probiotic (Calsporin) for the best of both approaches.
Conclusion
The emerging evidence for Lactobacillus helveticus HA-122 tells a consistent story across multiple experimental models: this heat-inactivated postbiotic strengthens the gut barrier, restores microbial balance after disruption, boosts short-chain fatty acid production, and calibrates immune responses — all without requiring live bacterial viability. From the canine gut simulators of Duysburgh (2025) and Deschamps (2025) to the zebrafish feeding trials of Rawling (2023) and Nikapitiya (2026), and validated in human clinical use by Martinelli (2017), the mechanisms are reproducible and the biological logic is clear.
What makes HA-122 particularly compelling for everyday use is its practical resilience. As a tyndallised postbiotic, it remains fully stable through manufacturing, storage, and feeding — delivering its bioactive cell wall components, surface-layer proteins, and immune-signalling molecules consistently with every dose. There are no viability concerns, no cold-chain requirements, and no gastric survival bottleneck.
Within Bonza’s food-plus-supplement system, HA-122 doesn’t work alone. The Superfoods & Ancient Grains complete food establishes the prebiotic and microbial foundation — chicory root inulin, Calsporin, and yeast cell wall fractions creating the gut environment in which postbiotic support can thrive. The Bioactive Bites supplement range then layers HA-122 alongside condition-targeted botanicals and nutraceuticals, delivering concentrated postbiotic benefits where they are needed most. This layered approach reflects both the science of synbiotic synergy and Bonza’s founding conviction: one gut, whole dog.
Canine-specific clinical trials on HA-122 as a standalone ingredient are still on the horizon. But the direction of evidence — strain-specific canine in vitro data, in vivo mechanistic validation, and human clinical proof of the exact tyndallised form — provides a robust foundation that will only strengthen as the research matures.
About the Author
Glendon Lloyd | Dip. Canine Nutrition (Dist.) | Dip. Canine Nutrigenomics (Dist.) | Founder, Bonza
Glendon specialises in evidence-based canine nutrition, with a focus on gut microbiome science, nutrigenomics, and the development of plant-based functional foods for dogs. He reviews 5–6 peer-reviewed studies weekly to ensure Bonza’s formulations reflect the latest advances in companion animal nutrition research.
Editorial Information
| Last reviewed | February 2026 |
| Next review due | February 2027 |
| Author | Glendon Lloyd, Dip. Canine Nutrition (Dist.), Dip. Canine Nutrigenomics (Dist.) |
| Medical disclaimer | This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen. |
